Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Mar;27(3):190-191.
doi: 10.1111/resp.14219. Epub 2022 Feb 9.

Friend or foe? Corticosteroids in sarcoidosis

Margaret L Wilsher  1   2
Affiliations
Free article
Editorial

Friend or foe? Corticosteroids in sarcoidosis

Margaret L Wilsher. Respirology. 2022 Mar.
Free article
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Sikjaer M, Hilberg O, Ibsen R, Lokke A. Sarcoidosis-related mortality and the impact of corticosteroid treatment - a population based study. Respirology. 2022;27(3):217-25.
    1. Rossides M, Kullberg S, Askling J, Eklund A, Grunewald J, Arkema EV. Sarcoidosis mortality in Sweden: a population-based cohort study. Eur Respir J. 2018;51(2):1701815.
    1. Spagnolo P, Rossi G, Trisolini R, Sverzellati N, Baughman RP, Wells AU. Pulmonary sarcoidosis. Lancet Respir Med. 2018;6(5):389-402.
    1. Gottlieb JE, Israel HL, Steiner RM, Triolo J, Patrick H. Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy. Chest. 1997;111(3):623-31.
    1. Judson MA. Corticosteroids in sarcoidosis. Rheum Dis Clin North Am. 2016;42(1):119-35, ix.

MeSH terms

Substances

LinkOut - more resources